Forepont Capital Partners

Forepont Capital Partners is a venture capital firm specializing in healthcare and life sciences investments, with a strong emphasis on neurotechnology. The firm is headquartered in New York and maintains a significant presence in Europe, including offices in London and Paris. Forepont focuses on early-stage companies in the United States and Europe, providing scientific, technological, financial, and operational support to enhance portfolio company performance. The firm's mission is to positively impact patient lives through investments in biotech, medtech, and digital health startups.

The firm's investment strategy targets a wide range of stages, from seed to pre-IPO, and spans various industries within healthcare and life sciences. Forepont has developed strong partnerships with industry leaders, including physicians, researchers, academic institutions, hospitals, and large pharmaceutical groups, primarily in the field of neurology. These collaborations have significantly contributed to the firm's success and the development of a proprietary deal flow.

Forepont Capital Partners has a track record of active investments, with recent funding rounds in companies such as Okeiro, BCV, Precision Neuroscience, and Synchron. The firm's approach includes providing permanent capital to strengthen partnerships with asset managers and actively participating in the operational aspects of portfolio companies to drive growth and profitability. Forepont's commitment to investing in the future and the common good is also reflected in its practice of donating 10% of its revenues to the Neurogen Research Foundation.